A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19)

Study protocol

Initial protocol

d8111r00006-pass-clinical-study-protocol_Redacted

English (1.35 MB - PDF) View document

Updated protocol

D8111R00006_Protocol v4.0 Redacted (Apr23)

First published: 22/02/2024

English (1.79 MB - PDF) View document

Study results

Study report

AZD1222 PASS_Interim Report 1_Final_21Apr2022_Redacted

English (5.47 MB - PDF) View document

d8111r00006-pass-final-report_final-v1.0_12Dec2024_Redacted.pdf

English (14.5 MB - PDF) View document

Other information

Secondary tabs